Long-term outcomes of common atrioventricular valve plasty in patients with functional single ventricle

Yusuke Misumi1, Takaya Hoashi, Koji Kagisaki

  • 1Department of Pediatric Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Insights

Common atrioventricular valve regurgitation is a risk factor for mortality in single ventricle patients. Surgical repair (CAVV plasty) offers improved survival, though reoperation may be necessary.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Common atrioventricular valve regurgitation (CAVV) is a significant risk factor for mortality and Fontan completion in patients with functional single ventricle.
  • Effective management of CAVV regurgitation is crucial for improving outcomes in this complex patient population.

Purpose of the Study:

  • To review the surgical experience with common atrioventricular valve plasty (CAVV plasty) in candidates for the Fontan operation.
  • To evaluate the long-term outcomes, survival rates, and need for valve replacement after CAVV plasty.

Main Methods:

  • A review of 38 consecutive Fontan candidates who underwent CAVV plasty between 1995 and the present.
  • The modified Alfieri technique using a polytetrafluoroethylene (PTFE) bridging strip was the primary repair method used.
  • Follow-up data were collected for a mean of 7.1 years, assessing survival and freedom from CAVV replacement.

Main Results:

  • Actuarial survival rates at 1, 5, and 10 years were 81%, 70%, and 67%, respectively.
  • Freedom from CAVV replacement rates at 1, 5, and 10 years were 89%, 85%, and 75%, respectively.
  • Twenty-three patients (61%) completed the Fontan operation; mortality was associated with total anomalous pulmonary venous connection and CAVV plasty performed before bidirectional Glenn (BDG).

Conclusions:

  • CAVV plasty remains a challenging procedure in functional single ventricle patients, but aggressive surgical intervention can improve long-term prognosis.
  • The ventricular unloading effect of BDG alone did not consistently maintain CAVV function, suggesting that CAVV replacement should be considered for severe regurgitation.
  • While the modified Alfieri technique showed promise, further follow-up is needed to confirm its long-term therapeutic superiority.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K